International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes. A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV.
| YEAR | Impact Factor |
|---|---|
| 2024-25 | 2.5 |
| 2023 | 2.1 |
| 2022 | 2.6 |
| 2021 | 2.023 |
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 0268-1315, LIPPINCOTT WILLIAMS & WILKINS, Medicine.